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Irreversible sickled cells, commonly referred to as ISC's, are red blood cells
found in individuals with a hereditary hemoglobin disorder called sickle cell anemia.
The ISC is best characterized and identified by its sickled shape; a unique property
of this cell is its inability to assume the normal biconcave shape. Reasons for this
irreversible shape change remain elusive, however, there is compelling evidence that
the defect which is responsible for the maintenance of this abnormal shape resides
within the cytoskeleton (Lux et al., 1976), a complex of proteins located on the
cytoplasmic face of the membrane whose putative functions include the control of;
(1) cell shape (Palek and Liu, 1979); (2) membrane integrity (Fairbanks, 1980;
Marches! et al., 1969); (3) mobility of surface determinants (Fairbanks et al., 1978;
Sheetz et al., 1980); and (4) deformcJjility (Evans et al., 1977; LaCelle et al., 1977).
Research evidence has revealed only one mutation associated with sickle cell
anemia which is in the 6-chain of hemoglobin, where glutamic acid is substituted by
valine at the sixth position (Ingram, 1956). This defective hemoglobin (hb-S) poly¬
merizes under low O2 tension, and as a consequence the cell sickles. It is known that
ISC's have an abnormal membrane and a host of other abnormalities, for example, an
abnormal distribution of cations (i.e., and Ca^ ; with subsequent cell dehydra¬
tion. These latter changes may also be due to changes within the membrane. It is
speculated that the membrane abnormality occurs when polymerized hemoglobin
perturbs the normal state of the membrane.
A correlation between the percentage of ISC's and the severity of the disease
has yet to be demonstrated, however, experimental results on rats injected with
ISC's revealed that these cells were preferentially lodged in capillaries. If, in fact,
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these ceils initiate vaso-occlusions in sickle cell anemics, it is conceivable that
preventing the formation of ISC's or converting these cells to the normal biconcave
shape, should reduce the frequency of vaso-occlusive crisis. Understanding the
defect(s) responsible for the maintenance of the sickle shape will possibly lead to the
development of new therapy for sickle cell disease.
In a previous attempt to identify the defect(s) responsible for this abnormal
shape, cytoskeletons from normal and irreversible sickled cells were compared for
protein compositional difference(s). But, no differences were observed (Lux et al.,
1976). Dissolution of ISC cytoskeletons in the presence of the detergent sodium
dodecyl sulfate (SDS) implies the absence of covalent association between the
constituent polypeptides. The interactions responsible for fixation of the abnormal
cell shape are presumably non-convalent ones.
Employing electrophoretic techniques of greater resolving power than those
previously used, cytoskeletons of normal erythrocytes and ISC's were examined.
Furthermore, to identify possible organizational differences between the two cyto¬
skeletons, a battery of crosslinking reagents was utilized.
CHAPTER II
REVIEW OF LITERATURE
Sickle cell anemia is a hereditary disease that is characterized by the
production of abnormal hemoglobin. The abnormal molecule called hemoglobin S,
was first detected by Pauling et al. (1949), although the nature of the defect in the
molecule was not identified until later (Ingram, 1956). The abnormal hemoglobin
results from a single point mutation that gives rise to a single amino acid
substitution whereby the amino acid valine is substituted for glutamic acid at the
sixth position of each beta chain of adult hemoglobin. The amino acid substitution
leads to the crystallization of hemoglobin when the molecule is in the deoxyconfor-
mation (Bertles and Milner, 1968). As a consequence, the cell shape is distorted into
an abnormal sickle shape.
Beet (1949) cind Neel (1949) demonstrated that sickle cell anemia was a
hereditary disease. They showed that the disease was inherited as if it were due to a
single recessive gene. The normal allele is denoted A and the mutated allele which
produces abnormal hemoglobin as S. Individuals with the abnormal allele (sickle
gene) may have one of the following genotypes, A/S or S/S. Individuals with the S/S
genotype have sickle cell anemia, while individuals denoted A/S are heterozygous for
the mutant gene and are free of the characteristic symptoms of the disease.
Sickle cell anemics experience a broad spectrum of clinical problems. The
most prevalent symptom is the vaso-occlusive crisis, sometimes referred to as the
"pain crisis". The pain crisis results from local intravascular sickling, stasis and
vaso-occlusion. The severity and frequency of the pain crises are variable. Other
acute vaso-occlusive episodes include pulmonary or central nervous system infarc¬




An effective therapeutic treatment for sickle cell anemia is still being sought.
In combating the pain crisis, several approaches have been attempted. The current
approaches are designed basically to alleviate pain and to protect the affected
organs. The primary treatment generally includes analgesics for pain relief,
hydration (increased plasma water content to decrease blood viscosity) and
antibiotics for bacterial infections. Blood transfusion is generally recommended
when an acute crisis is deteriorating; however, transfusions are not recommended
for prolonged periods of time, because upon destruction of red cells, "iron overload"
may occur, which leads to other clinical problems. Transfusion also causes other
problems such as hepatitis and allergic responses.
Murayama (1966) proposed that polymerization of deoxygenated (deoxy)
hemoglobin S was due mainly to hydrophobic interactions of the molecule. This
concept stimulated the study of chaotropic agents as antisickling agents (Power,
1975). Urea, among the first chaotropic agents to be used was shown to inhibit
sickling in vitro (Cerami and Manning, 1971) but was ineffective in vivo at tolerable
dosages (Rhodes et al., 1974). Other chaotropic agents have been studied including
alkyl ureas, organic solvents and detergents. Although these latter reagents prevent
sickling in vitro, they are not without toxic side effects.
Cyanate, a derivative of urea, has been extensively investigated as an
antisickling agent. This compound prevents aggregation of hemoglobin by stabilizing
the oxygenated form of the molecule (Cerami, 1974). Pilot studies using oral
cyanate revealed increased red cell survival, a slight increase in oxygen affinity and
a slight decrease in the number of vaso-occlusive crises (Gillette et al., 1974).
However, another study demonstrated no decrease in the number of pain crises
(Harkness and Roth, 1975) and revealed evidence of toxicity from oral administra-
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tion (Harkness and Roth, 1975; Peterson et al., 1974). The administration of cyanate
extracorporally is still being investigated as a possible treatment for the disease.
Another therapeutic approach aims at preventing polymerization of hemoglo¬
bin S by decreasing the concentration of hemoglobin. Studies by Eaton et al. (1973)
and Hofrichter et al. (1974) showed that a small decrease in the concentration of
deoxy hemoglobin S can produce a substantial increase in the delay time for
polymerization.
Another method of decreasing the concentration of hemoglobin S is to induce
the bone marrow to produce either; (1) fetal hemoglobin (Hb-F) or (2) normal
hemoglobin (Hb-A) (from newly inserted genes). This represents a potential method
for the future.
A third therapeutic approach for combating the painful crisis of sickle cell
anemia employs agents that act on the erythrocyte membrane. Cetiedil (a local
anesthetic used for the treatment of chronic cardiovascular diseases), is a lipophilic
molecule which inserts into the erythrocyte membrcine inhibiting sickling of the
abnormal cell. The exact mechanism by which it inhibits sickling is unknown.
Preliminary studies suggest that the drug alleviates sickle cell crisis. Other agents
that act on the erythrocyte membrane are zinc and thorazine (a tranquilizer) both of
which are inhibitory of calmodulin, an intracellular Ca receptor. Procaine
hydrochloride, a cationic anesthetic, has also been demonstrated to decrease
membrane rigidity.
Vasodilators have been used for the treatment of pain crisis. Dilation of blood
vessels may inhibit entrapment of sickle cells in the microvascular system.
Therapeutic agents discussed here are all effective to some degree, but are not
without adverse side effects. Though these agents offer some promise in combating
the disease, others are currently under extensive investigation.
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In the circulatory system of sickle cell anemics, there exists a population of
cells that becomes irreversibly locked into a sickle shape upon deoxygenation.
Unlike non-irreversible sickled cells (non-ISC's), irreversibly sickled cells (ISC's) do
not return to the normal biconcave shape upon oxygenation. ISC's are abnormal
crescent shaped red blood cells (Diggs and Bibb, 1939; Murphy and Shapiro, 1945). In
contrast to the normal erythrocyte, ISC's also possess the following abnormal
characteristics: decreased viscoelasticity (Chien et al., 1970), increased calcium
concentration (Eaton et al., 1973), decreased ATP level (Weed and Bessis, 1975;
Sergeant et al., 1969), increased rate of hemolysis in vivo (Bertles and Milner, 1968),
decreased cind cell water, increased cell Na^ (Segal et al., 1974; Glader et al.,
1974), increased hemoglobin concentration (Bertles and Milner, 1968), increased
membrane associated hemoglobin (Lessin and Wallas, 1973), a faster rate of loss of
deformability upon deoxygenation and a slower rate of regain of deformability upon
reoxygenation (Hahn et al., 1976).
ISC's vary in proportion in the circulatory system of sickle cell anemics from
an average of 5 to 50% (Diggs, 1956; Bertles and Milner, 1968; Sergeant et al., 1969).
It has been proposed that ISC's contribute to pain crisis, yet there is no correlation
between the percentage of ISC's and the frequency at which the pain crisis occurs
(Diggs, 1956). There is a direct correlation between the percentage of ISC's and the
rate of hemolysis (Sergeant et al., 1969; McCurdy and Sherman, 1978), the
malfunction of the spleen (Sergeant, 1970) and conjunctival blood vessels abnormali¬
ties (Sergeant et al., 1972). In a rat model, ISC's are preferentially lodged in
capillaries, suggesting that they may indeed play a roll in initiating vaso-occlusive
crisis (Klug et al., 1974).
The exact mechanisum by which ISC's are formed is not known. There are
many factors which seem to contribute to their formation. It is possible that the
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most critical alteration is membrane damage, which may result from repeated
cycles of sickling and unsickling (Padilla et al., 1973).
Shen et al. (1949) demonstrated that prolonged anaerobic (without oxygen)
incubation leads to the formation of ISC's. Other factors possibly leading to ISC
formation include: decreased intracellular (Glader and Miller, 1975); increased
Ca^^ concentration (Eaton et al., 1973); membrane loss (Bertles and Milner, 1968);
and membrane-associated hemoglobin (Lessin and 3ensen, 1974). The available data
suggests that all of these abnormal properties, in conjunction with each other
contributes to the formation of ISC's.
In red blood cells, the structural components for shape appear to be contained
within the membrane since isolated membrcines retain the biconcave shape
characteristic of the intact cell. Beneath the lipid-protein bilayer exists a network
of peripheral membrane proteins called the cytoskeleton. The cytoskeleton is
defined operationally as the interconnected proteins that remain after a celi or
membrane (ghost) has been extracted with a non-ionic detergent such as Triton X-
100.
Electron microscopic studies by Nicholson et aL (1971) showed that the
cytoskeleton is closely associated with the cytoplasmic surface of the membrane.
Yu et al. (1973) were the first to demonstrate that the cytoskeleton retained the
approximate size and shape of tiie intact red cell. The appearance of the
erythrocyte cytoskeleton has been studied by Hainfield and Steck (1977), Sheetz
(1979) and described by Tilney and Detmers (1975) as "...an anastomosing
framework like a net woven by a myopic fisherman."
The cytoskeleton comprises approximately 60% of the total membrane protein
mass and includes the following; Spectrin (bands 1 and 2), Actin (band 5), bands 4.1,
4.9 and 7 (Sheetz, 1979). Other proteins found eissociated with the cytoskeleton are
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Ankyrin (bands, 2.1, 2.2, 2.3 and 2.6), bands 3 and 4.2. These latter proteins are not
considered to be integral components of the cytoskeleton. Band 3 appears to be the
major anion channel in the membrane (Rothstein et al., 1979) and ankyrin attaches
the cytoskeletal network to the membrane via the cytoplasmic domain of band 3.
The function of band 4.2 has not yet been defined.
Spectrin is the major protein of the network and comprises about 75% of the
cytoskeleton protein mass (Lux et al., 1976). It is composed of two subunits, band 1
(a-chain, molecular weight - 240,000 daltons) and band 2 (3-chain, molecular weight
- 200,000 daltons) which are structurally similar but nonidentical (Anderson and
Tyler, 1979). Spectrin exists as a heterodimer (1+2) or heterotetramer (I2+22)
(Ralston et al., 1977). The tetramer is thought to be the physiological species in the
erythrocyte (Ungelwickell and Gratzer, 1978).
Several investigators have suggested that erythrocyte actin (molecular weight
= 55,000 daltons), is in a nonfilamentous state (i.e., G-actin), complexed with other
cytoskeletal proteins (Finder et al., 1975; Tiiney and Detmers, 1975). This idea
remains a controversial issue. Actin filaments are not visible in electron
micrographs of red blood cell membranes and the amount of actin present is not
compatible with the existence of long actin filaments, however, short oligomers may
be present.
Studies of band 4.1 (molecular weight = 78,000 daltons) indicate that it plays
an integral role in maintaining the supramolecular structure of the cytoskeletal
complex. Fowler and Taylor (1980) reported that an oligomeric complex of spectin,
actin and band 4.1 causes actin to gel and that purified spectrin and actin tetramers
lack this activity, suggesting that band 4.1 is required for crosslinking. Tyler et al.
(1980) reported that purified band 4.1 binds to spectrin in the absence of actin
indicating a specific interaction of 4.1 with spectrin.
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An important function of the cytoskeleton is the control of red cell shape.
Molecules such as ATP and 2,3-Diphosphoglycerate have been shown to dissociate
the cytoskeletal complex (Sheetz et al., 1980). It has also been demonstrated that
these metabolites cause a shape transformation from a discocyte to an echinocytic
shape and concommitant vesiculation. Cytoskeletons extracted from ISC's retain
the shape typical of the ISC suggesting that defects responsible for the abnormal
shape resides within this complex (Lux et al., 1976); the defect(s) itself has yet to be
identified.
In some hemoglobinopathic cells, the defects within the cytoskeleton are
better understood. Cytoskeletons from hereditary pyropoikilocytes (HPP) are
unstable and exhibit irregularities in electron density, suggesting abnormalities in
cytoskeletal assembly (Palek, 1981). HPP spectrin exhibits abnormalities which
include decreased extractability from membranes (Wiley and Gill, 1976) and
increased susceptibility to thermal denaturation (Chang et al., 1979). Cytoskeletons
from hereditary elliptocytes (HE) also exhibit an abnormal shape. In these red cells,
spectrin is abnormally heat sensitive and denatures at a lower temperature than
normal (Tomaselli et al., 1981). Some patients with hereditary elliptocytosis have
spectrin that yields abnormal trypsin-digestive fragments (Coltzer and Zail, 1981)
and cytoskeletons from some patients with elliptocytosis have been observed to lack
band 4.1 (Cohen and Branton, 1981; Tchernia et al., 1981). Studies on hereditary
spherocyte (HS) cytoskeletons suggest that interactions between band 4.1 and
spectrin in some patients is defective (Cohen and Branton, 1981). A mutant strain of
the mouse Mus musculus exhibits a severe form of spherocytic anemia. Erythrocyte
membranes from this mutant show a marked decrease in spectrin (Greenquist et al.,
1978). Spectrin deficiency correlates with the degree of hemolysis (Lux, 1979) and
incorporation of normal spectrin into these membreines results in improved
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structural integrity (Shohet, 1979). These findings suggest that defects within the
cytoskeleton may be responsible for the abnormal cell shapes. To say that they are
the primary lesions of the cells rather than secondary ones remains unanswered.
The cytoskeletal complex also participates in the stability of the membrane,
its deformability and the lateral mobility of certain transmembrane proteins (Lux,




Blood was obtained from die Sickle Cell Foundation of Georgia and Herman
Harris, Administrative Officer of the Comprehensive Sickle Cell Center of the
Medical College of Georgia, Augusta, Georgia. Blood obtained had been identified
as homozygous for the sickie (S/S) gene. Individuals had not been transfused within
a three month period prior to phiebotomy. Normal (A/A) blood was obtained from
paid volunteers.
SEPARATION OF IRREVERSIBLE SICKLED CELLS (ISC's)
Blood was transferred to clinical centrifuge tubes and centrifuged for ten
minutes (min) in a Dynac Ciinical centrifuge at 100 rpm at 4°C. The plasma and
buffy coat were removed and discarded. The remaining packed cells were suspended
in wash buffer calied 5PN(8) (0.15M NaCl, 5mM NaPO^, pH 8), centrifuged as above
and the supernate discarded. The procedure of Abraham et al. (1975) wea adopted
for separating ISC's with some modifications. Dextran - 40 solutions of various
concentrations were prepared by dissolving appropriate quantities in a suspension
medium consisting of 585 mg KH2POj|^, 3141 mg NaH2P0^.H20, 8600 mg glucose,
6277 mg NaCL, 96 mg MgSO^ with water added to make the total volume 1000 ml
(pH 7.4). A blood volume of 1.5 to 2.0 milliliters (ml) was layered on a Dextran-40
(molecular weight 40,000) discontinuous gradient ranging from 24% to 34% with a
60% cushion to prevent pelleting of ceils (Fig. 1). The total volume was 34 ml with
4.5 ml for each layer. Blood was centrifuged in a Beckman 25.1 swinging bucket
rotor in a Beckman L5-50 Ultracentrifuge at a speed of 90,000 x g (24,000 rpm) at
4°C for 1.5 hours (hr). Centrifugation of ceiis (normal and sickle) resulted in the
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Figure 1. Diagrammatic representation of the Dextran - 40 step gradient used to
fractionate erythrocytes. Each layer consisted of 4.5 ml of the












34 milliliters total capacity
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separation of six distinct bands of red blood cells. The bottom band in the sickle
gradient appeared darker in intensity than the normal bottom band. After
centrifugation, the two closest fractions were combined to yield three fractions
varying in the percentage of ISC’s: Top fraction (approximately 9%), middle fraction
(approximately 20%) and the bottom fraction (approximately 71%). Fractions were
washed twice in 5PN(8) and subsequently centrifuged in an International Equipment
Centrifuge (lEC) for ten min at 35,000 x g (16,000 rpm) and the supernate was
discarded.
SCORING OF ISC’S
Packed cells were resuspended in 5PN(8) and incubated under 95% oxygen and
5% carbon dioxide for five min with mild agitation. An aliquot of suspended blood
Wcis removed and fixed in 4% giutaraldehyde in 5PN(8) solution. Cells from each
fraction were viewed with a Swift International Phase Contrast Microscope. ISC’s
were defined as elongated crescent shaped cells whose length to width ratio was
greater than 2:1. A total of 500 cells were counted to determine the percentage of
ISC’s in each fraction. Normal cells were also viewed with the phase contrast
microscope to determine if the fractionating conditions altered the cell morphology.
PREPARATION OF MEMBRANES AND CYTOSKELETAL COMPLEXES
The method of Fairbanks et al. (1971) was employed for preparing membranes
(Fig. 2). Packed intact cells were washed three to four times with an isotonic buffer
(5PN(8)) in a clinical centrifuge and then lysed in a hypotonic solution called 5P(8)
(5mM sodium phosphate, pH 8.0). They were subsequently washed three to four
times in the same buffer using the lEC centrifuge until membranes were free of
hemoglobin (white).
Cytoskeletal complexes from both intact cells and membranes were prepared
according to the procedure of Sheetz (1979) with the following modifications (Fig.
Figure 2. General scheme for analyzing membrane proteins.
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3). Cells or membranes (ghosts) were suspended 1:1 in extraction buffer (6M KCl,
48mM Hepes/Ringer (pH 7.4), l.OmM MgCl2, 0.05mM CaCl2 and 3% Triton X-100).
The suspended cells (or membranes) were extracted for 30 min at 4°C (in an ice
bath) at 120 oscillations per min on a rotary shaker. Samples were then centrifuged
for 30 min in the lEC at 65,000 x g at 4°C. The supernate was aspirated and
discarded; the pellet (cytoskeletal complexes) was resuspended in 5PN(8) and washed
until free of hemoglobin. The washed pellet was resuspended in 5PN(8) at a
concentration of three to four milligrams (mg) per ml. The cytoskeletal protein
concentration was assayed by the Lowry (1951) method.
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS
One dimensional polyacrylamide gel electrophoresis was performed as
described by Fairbanks et al. (1971) and Laemmli (1970). Four percent cylindrical
(5mm i.d. x 10.5 cm) Fairbanks gels were prepared from a stock of 30% acrylamide
and 0.8% bisacrylamide. The Laemmli system was used to prepare slab gels.
Polyacrylamide slab gels were prepared in the Hoeffer Vertical Slab
Apparatus, with glass plate dimensions of 1.5 millimeters (mm) x 14 centimeters
(cm) X 18 cm. After the plates were assembled, 5% and 15% acrylamide solutions
were prepared, each of whidi had a total volume of 12.5 ml. Twelve microliters (yl)
of tetramethylethylenediamine (TEMED) and 24 Ul of 10% ammonium persulfate
(catalysts) were added to the 15% solution and the solution was then poured into the
exit dnamber of a linear gradient maker. The valve connecting the two chambers
was briefly opened to allow back flow of the 15% solution to prevent entrapment of
bubbles in the canal between the two chambers. The 5% acrylamide solution was
subsequently added to the other chamber of the gradient apparatus, after adding 12
yl of TEMED and 32 yl of 10% ammonium persulfate. Stirring bars were added to
each chamber, and the exit port and valve between chambers opened. The
Figure 3. General scheme for preparing cytoskeletons from membranes and
intact red blood cells, and analyzing their protein composition.
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MEMBRANES OR RED BLOOD CELLS (SICKLE OR NORMAL)
I EXTRACT WITH 3% TRITON X-100
I IN EXTRACTION BUFFER
MEMBRANE OR RED BLOOD CELL EXTRACT
(soluble fraction)
DISCARD PELLET (insoluble FRACTION,
CYTOSKELETONS)
SUPERNATE
CENTRIFUGE IN WASH BUFFER
(isotonic 5pn)
UNTIL FREE OF HEMOGLOBIN
PELLET (washed CYTOSKELETONS)
I SOLUBILIZE, SUBJECT TO




TYPICAL APPEARANCE OF CYTOSKELETAL
PROTEINS ON POLYACRYLAMIDE GELS





acrylamide gradlCTit solutions exiting the gradient maker filled part of the volume
between the two plates in the gel apparatus. The acrylamide solution between the
two plates was subsequently overlayered with butanol and allowed to polymerize for
one hour. After the gel (separating) was polymerized, the butanol overlayer was
removed and replaced with Laemmli electrophoresis buffer. The gel was tfien
allowed to stand overnight at room temperature. The overlayer solution was then
removed and after blotting the separating gel interface with a soft tissue, a 4.5%
stacking gel solution was poured on top. A 10-well comb was inserted into the
stacking gel prior to polymerization to form the lanes for the samples to be applied.
After 30 min, the comb was carefully removed from the polymerized gel and the
residual unpolymerized gel solution aspirated.
The base of the gel chamber was removed and the gel Wcis placed inside the
lower buffer reservoir. The upper and lower reservoirs were filled with
electrophoresis buffer and the samples applied in the various lanes. A cannular
(pipette bent at the end) was used to remove bubbles from the bottom of the glass
plates. The electrodes were then connected to a power supply that maintains
constant milliamperes (ma). The power supply was adjusted to 20 ma per gel.
Electrophoresis was terminated when the tracking dye was at the end of the gel.
The gel wcis then removed from the glass plates by prying them apart with a spatula.
It was placed in 0.05% Coomassie blue R-250, 25% isopropyl alcohol, 15% acetic
acid (Fairbanks et al., 1975), and stained a minimum of 12 hours. Subsequently, it
was destained in 10% isopropyl alcohol and 10% acetic acid. After destaining, the
gel was viewed upon a fluorescent lamp box.
Isoelectric Focusing (lEF)
Isoelectric Focusing was performed as described by O'Farrell (1975).
Ampholytes were omitted from the solubilization buffer and the urea concentration
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in the buffer was adjusted to its saturation point. Gels were poured as described by
O'Farrell and overlayed with butanol. After two to three hours, the butanol was
replaced with 20 ul of sample overlayer solution and the gel was allowed to
polymerize for another one to two hours. After polymerization, gels were mounted
in the standard cylindrical gel apparatus. They were prefocused for 15 min at 200
volts, 30 min at 300 volts, and finally 30 min at 400 volts. The upper (cathode) gel
chamber was filled with fresh 0.025 M NaOH, which had been degassed by boiling
and stored in a tightly sealed container. The lower (anode) reservoir was filled with
0.03M H2P0^.
One volume of protein sample at a concentration of 3-4 mg/ml was diluted in
0.5 ml of 2% (w/v) NP-40 and 5% 3-mercaptoethanol. Samples were vortexed and
boiled for five min and again subjected to mixing. They were then cooled in a cold
water bath and crystalline urea weis added to a concentration of 9M. Samples were
then centrifuged in a Brinkman Micro Centrifuge for two min and the supernate was
applied to the first dimension tube gel (lEF) and overlayed with diluted sample
overlayer solution.
Electrofrfioresis was performed at 400 volts for 12 hours and 800 volts for the
13th hour. Proteins were identified by the staining procedure of Tuszynski et al.
(1978).
A blank isofocused gel was used to determine the pH gradient when
electrophoresis was ended. Gel pH was measured with an automatic single contact
electrode, connected to a standard pH meter. In some cases, pH readings were made
after cutting a blank gel in 5mm slices and placing each into 2 ml of degassed water,
where they were shaken for five to ten min. The pH of each solution was
subsequently determined with the pH meter.
Isofocused gels to be subjected to SDS-electrophoresis (second dimension) were
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not stained but equilibrated with one volume of 0.0625 M Tris-HCl, pH 6.8, 2% SDS,
10% glycerol and 5% Beta-mercaptoethanol for one min by mild agitation.
Two-Dimensional Polyacrylamide Gel Electrophoresis (lEF/SDS PAGE)
lEF Gels to be placed on SDS-Slab gels were equilibrated as described above.
After equilibration, they were sealed on top of the stacking gel with a 1% agarose
solution. Electrophoresis was initiated at 100 volts until the dye front entered the
separating gel and then the voltage was increased to 125 volts. Electrophoresis was
ended when the tracking dye reached the bottom of the gel. Gels were removed
from the vertical apparatus and stained according to Fairbanks et al. (1971).
GELCODE STAINING PROCEDURE
Polyacrylamide slab gels were shaken in 5% ethyl alcohol (ETOH) - 10% acetic
acid (HAc) for two hours and this was repeated once in fresh solution. They were
then transferred to a 40% ETOH - 10% HAc solution and again stirred for two hours.
This latter solution was then replaced with 10% ETOH - 0.5% HAc and the gels
shaken for one hour; following this step, they were shaken for another hour in fresh
10% ETOH -0.5% HAc.
The final fixing solution was decanted and Gelcode reagent 1_ (entire contents
dissolved in 1000 ml H2O) poured on to the gel. The gel was then shaken for two
hours.
Reducing reagent (2.25 ml of reagent 4 per 300 ml of solution 2 (reagent 2 plus
reagent 3 dissolved in 2000 ml)) was prepared fresh and added to the gel after
washing the gel for 10-20 seconds in deionized water. The gel was shaken in
reducing agent for ten min. Usually color development began immediately upon
adding reducing reagent; it Wcis stopped by adding 5% HAc. Gels were subsequently
stored in this latter solution.
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SILVER STAINING PROCEDURE
Polyacrylamide sleib gels were stirred in 40% methanol (MeOH) - 10% HAc for
30 min, and after decanting the above solution, the gels were stirred in 10% ETOH -
5% HAc for 15 min. The latter solution was replaced with a fresh solution and
stirring continued for 15 min.
After removing ETOH - HAc, oxidizing solution (BioRad) (20 ml commercial
stock dissolved in 180 ml deionized water) was added to the gel. The gel was
allowed to stand in this solution for 20 min with occasional shaking. The oxidizing
solution was decanted and the gel then washed once with deionized water. The gel
was then placed in silver reagent (20 ml stock silver solution and 180 ml deionized
water) for 20 min with mild agitation and then washed with deionized water until the
gel became clear.
Developing solution (BioRad) (entire contents of commercial stock plus 3.6
liters of deionized water) was added to the gel after removing the water wash. The
gel was allowed to stand in developer for 30 seconds with constant agitation, before
the solution was replaced with fresh developer. The gel was then allowed to stand
for five min in the latter solution with gentle agitation. This last step was repeated
until the bands reached the desired intensity. Development was stopped by
decanting the developer and adding 5% HAc. Gels were subsequently stored in this
latter solution.
CROSSLINKING OF CYTOSKELETAL COMPLEXES
A. O-phenanthroline/Copper Sulfate: (O-phe/CuSO^) dissolved in 5mm
Sodium Phosphate buffer, pH 8.0 (5P(8)) was added to 20 volumes of cytoskeleton
suspension (i.e., 5 ml O-phe/CuSO^ to 100 ml of cytoskeleton suspension).
Cytoskeletons were crosslinked with O-phe/CuSO^ (Steck, 1972) at various concen¬
trations ranging from ImM to lOmM. Incubations were carried out on a rotatory
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shaker at 120 oscillations per min at various time intervals, from 0 to 60 min. The
oxidative crosslinking reaction was stopped using Fairbanks solubilizing buffer
(4% SDS, 8mM Tris Acetate, 20% sucrose and pyronin y) at one-fourth the volume of
the cytoskeletons in the reaction mixture. Dithiothreitol (0.0248 grams (gm) per ml
of solubilizing buffer) was added to control cytoskeletons without crosslinking
reagent.
B. Glutaraldehyde; Cytoskeletons suspended in 5PN(8) were crosslinked
with glutaraldehyde (Steck, 1972). Crosslinking was allowed to occur at room
temperature at various concentrations and time periods and then stopped by the
addition of 4X Fairbanks solubilizing buffer containing dithiothreitol (0.0248 gm DTT
per ml of solubilizing buffer) at one-half the volume of cytoskeletons.
C. Dimethy 3,3’-Dithiobispropionimidate (DTBP): Cytoskeletons were sus¬
pended in 0.05M Triethanolamine buffer (pH 8.0) at a final concentration of 2 mg
protein per ml. DTBP dissolved in the same buffer was added in a 1:1 ratio and the
cytoskeleton suspension weis incubated at room temperature at various times and
concentrations. Crosslinking was terminated with 50 yl of IM ammonium acetate
(NHjAc) per yl of sample. The reaction mixture was then incubated at room
temperature for ten min and subsequently 50 yl of N-ethylmaleimide (NEM) (20 mg
per ml) and 200 yl of 20% (w/v) SDS were added (Wang and Richards, 1974). One
mg/ml of Pyronin y was used as a tracking dye.
D. Dithiobis (succinimidyl propionate) (DTSP): Cytoskeletons were sus¬
pended in 0.05M Triethanolamine buffer (pH 8.0) at a final concentration of 4mM
DTSP. DTSP dissolved in the same buffer was added in a 1:5 ratio and the
cytoskeleton suspension was incubated at room temperature at various times and
concentrations. Crosslinking was terminated with 200 yl of 20% (w/v) SDS in 25mM
NaPO^, ImM MgCl2» pH 8, and Img/ml of Pyronin y (Brandon, 1980).
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E. Dimethyladipimidate (DMA) and Dimethylsuberimidate (DMS): DMA and
DMS (60 mM) were dissolved in 0.5M Triethanolamine (pH 9.0) for separate
incubations. An aliquot of the crosslinking solution was added to the cytoskeleton
suspension in a 1:1 ratio. The reaction mixture was incubated at room temperature
at various time periods. Crosslinking was quenched by the addition of 4X Fairbanks
buffer at one-half the volume of the cytoskeletons. DTT (0.0248 g/mi of
solubilization buffer) was added to the controls and to the experiment sample.
PHOTOGRAPHY
Gels were photographed with a Polaroid 525 land camera with type 52 Polaroid
land film. A yellow filter was used to enhance contrast.
SCANNING ELECTRON MICROSCOPY
Red blood cells and membranes were fixed for 12 hrs by adding 1 volume of 4%
glutaraldehyde in 5PN(8) to 1 volume of sample. Samples were washed one to two
times for 15 min in deionized water, and dehydrated through a graduated series of
ethanol. Samples were then air dried or critical point dried using liquid carbon




EVALUATION OF TECHNIQUES FOR PREPARING CYTOSKELETONS
Comparison of Lux and Sheetz Procedures
Several techniques have been utilized to prepare erythrocyte cytoskeletons
(Lux et al., 1976; Sheetz, 1979). The following analyses were carried out in order to
directly compare these methods as well as to corroborate the value of the different
chemicals present in the buffer. A goed of this work was to define a cytoskeleton of
minimal protein composition which retained the shape of the cell. However,
structural definition of a minimum cytoskeleton has not yet been achieved because
of difficulties in visualizing isolated cytoskeletons with the electron microscope.
When membranes were extracted according to Lux et al. (1976) with 0.5%
Triton X-100, 56mM NaB^O^ (pH 8.0), at 0°C for 30 min, a cytoskeleton was
obtained containing all of the major cytoskeletal components: Spectrin (Bands 1 and
2), band 4.1, band 4.9, band 5 (actin) and small amounts of the non-cytoskeletal
polypeptides, bands 2.2, 2.3, 4.2 and 3 (Fig. 4, lane 2). In an attempt to remove all
of the non-cytoskeletal proteins, the concentration of the detergent (Triton X-100)
was increased ten fold (to 5%). High concentrations of Triton X-100 were effective
in removing the majority of band 3 and the other non-cytoskeletal proteins, yet
small amounts of the polypeptides remained associated with the cytoskeleton (Fig. 4,
lane 3).
Extraction of cytoskeletons employing Sheetz's procedure (1979) was more
effective in removing non-cytoskeletal constituents. The extraction buffer is a
Hepes-Ringer buffer (pH 7.4) containing 6M KCl and 5% Triton X-100. It has been
demonstrated by Sheetz (1979) that KCl augments the effect of Triton in the
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Figure 4. Electrophoresis of proteins in Triton - cytoskeletons prepared by the
Lux or Sheetz procedure. Electrophoresis was carried out on Fairbanks
4% sodium dodecyl sulfate (SDS) polyacrylamide gels and the proteins
visualized after staining with Coomassie brilliant blue. Gels; 1) Whole
erythrocyte membranes; 2) Triton - cytoskeletons prepared by the Lux
procedure (0.5% Triton X-100); 3) Triton - cytoskeletons prepared by
the Lux procedure (5% Triton X-100); 4) Triton - cytoskeletons
prepared by the Sheetz procedure (5% Triton X-100). Nomenclature






removal of integral membrane proteins (e.g., band 3). These cytoskeletons were
simpler in protein composition in that the majority of the non-cytoskeleton proteins
(bands 2.1, 2.2, 3 and 4.2) were absent (Fig. 4, lane 4).
The analyses in the following section were carried out to examine the effect of
the various components of the Sheetz extraction buffer on the cytoskeleton protein
composition.
The Effect of Triton X-IQO, KCl and Proteolytic Inhibitors in Preparing Cytoskele¬
tons
As the concentration of Triton X-100 was increased to 3%, non-cytoskeletal
proteins were progressively removed, however, 5% Triton X-100 was no more
effective than 3% Triton X-100 (Fig. 5). Because the volume of the 5% Triton X-100
insoluble fraction is significantly less than the 3% Triton X-100 insoluble fraction,
and since we only obtain a small volume of ISC's after fractionation, the use of 3%
Triton X-100 allowed us to obtain a visibje pellet of ISC cytoskeletons.
Two concentrations of potassium chloride (KCl) were used to examine the
effect of salt concentration; 6M KCl and 0.006 M KCl. It was noted by Sheetz
(1979) that concentrations greater than 0.3M KCl were far more effective than low
concentrations in removing non-cytoskeletal proteins. Analysis of cytoskeletal
proteins with the above concentrations of KCl confirmed the findings of Sheetz et
al. (Fig. 5, lanes 5 and 6).
It was suggested by Sheetz (1979) that pretreatment of cells and preparation of
cytoskeletons in the presence of the proteolytic inhibitor Diisopropylphospho-
fluoridate (DFP) prevented the proteolytic degradation of non-cytoskeletal proteins
(e.g., band 2.1), thereby enhancing their extraction with Triton X-100. Since there
was evidence of a proteolytic degradation product of band 2.1, namely band 2.3, in
cytoskeletons that were prepared in the absence of proteolytic inhibitors, the effect
Figure 5. Comparison of the effect of various concentrations of Triton X-100
and potassium chloride (KCl) on cytoskeleton protein composition.
Cytoskeletons were subjected to electrophoresis as in Fig. 7. Gels:
1) Whole erythrocyte membranes; 2) Cytoskeletons prepared in 0.5%
Triton X-100; 3) Cytoskeletons prepared in 1.5% Triton X-100;
4) Cytoskeletons prepared in 3% Triton X-100; 5) Cytoskeletons
prepared in 5% Triton X-100 with 6M KCl; 6) Cytoskeletons prepared
in 5% Triton X-100 with 0.006M KCl.
■26
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of DFP (20mM) in the pretreatment (Hepes-Ringer, pH 7.4) and the extraction buffer
was examined. Neither band 2.1 nor 2.3 appeared in the protein profile of
cytoskeletons prepared in the presence of DFP (Fig. 6). Despite DFP's effective¬
ness, it is not without great cost and some potential hazard (DFP is fatal if vapor is
inhaled and through skin contact). Therefore, its usage was discontinued.
Phenylmethylsulfonylfluoride (PMSF) and Trypsin inhibitors were also examined but
proved to be ineffective in inhibiting proteolytic degradation (data not shown).
Extraction was subsequently carried out in the absence of proteolytic inhibitors.
Comparison of Cytoskeletons Prepared From Isolated Membranes Versus Whole Cells
When cytoskeletons are prepared from membranes, it is conceivable that in the
process of their isolation, several deleterious processes could occur, namely;
(1) proteolytic degradation of membrane proteins due to protease activation
(2) change in the ionic environment and subsequent change in protein-protein
interactions. To avoid the occurrence of these processes, cytoskeletons were
routinely prepared from intact cells rather than from membranes. To determine
whether there was a difference in cytoskeletons from intact cells versus membranes,
both were extracted employing the Sheetz's procedure. Analysis of both prepara¬
tions on Fairbanks (4%) disc gels revealed that the two preparations were similar,
though the cytoskeletons from intact cells contained an additional band, band 7,
which was absent in membrane preparations (Fig. 7). This is consistent with what
has previously been reported by Sheetz (1979).
SEPARATION OF IRREVERSIBLE SICKLED CELLS (ISC'S)
To analyze the protein composition of ISC cytoskeletons, it was necessary to
isolate ISC's from non-ISC's. This was achieved when S/S whole cells were
fractionated on a Dextran - 40 discontinuous gradient. Fractionation was based on
density. ISCs have a higher density than normal cells, presumably due to the loss of
Figure 6. Effect of the presence of Diisopropylphosphofluoridate (DFP) in the
pretreatment buffer (Hepes-Ringer, pH 7.4) and the extraction buffer
on cytoskeletal protein composition. Cytoskeletons were subjected to
electrophoresis as in Fig. 4. Gels: 1) Whole membranes; 2) Cytoskele¬
tons prepared in the aJssence of DFP; 3) Cytoskeletons prepared in the
presence of DFP.
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Figure 7. Comparison of cytoskeletal proteins prepared from membranes and
intact cells. Cytoskeletons were subjected to electrophoresis as in
Fig. 4. Gels: 1) Whole membranes; 2) Cytoskeletons extracted from
membranes; 3) Cytoskeletons extracted from intact red blood cells.
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water during the cascade process of ISC formation. A 60% Dextrein cushion was
utilized to avoid pelleting of cells. This allowed collection of ISC's from the side
with an 18 gauge syringe. When the cushion was omitted, cells pelleted and adhered
to the walls of the tube making collection difficult. Both normal and sickle blood
yielded six bands of erythrocytes upon fractionation (Fig. 8). The bottom fraction of
sickle blood always showed a greater intensity than the corresponding band in the
normal blood indicating a greater number of dense cells. Each fraction was
collected and treated as described in Methods.
Observation of erythrocytes in each fraction with the scanning electron
microscope enabled visualization of cell shape and membrane surface texture (Figs.
9 and 10). As expected in the sickle blood, the percentage of ISC's increased
dramatically from top to bottom fractions (top, 9% ISC's; middle, 20% ISC's; bottom,
71% ISC's). The sickled cells in each fraction were presumably ISC's since they
retained the sickled shape after oxygenation for five min with 95% oxygen.
It has been reported that the surface of ISC's is often irregular but without
visible organization (Lessin et al., 1978) when viewed with the scanning electron
microscope and more recently, that some ISC's are echinocytic, i.e., have distinct
surface irregularities (Palek et al., 1978). A small percentage of the cells in the
bottom fraction speared to be echinocytic but the majority of them had a
nondescript shape with a slightly irregular surface. These observations are
consistent with previous reports.
No difference was noted in the shape and texture of normal erythrocytes
obtained from the top, middle and bottom fractions.
This analysis indicates that ISC's can readily be obtained by fractionating
sickle cell erythrocytes in Dextran step-gradients.
Figure 8. Fractionation of normal and sickle erythrocytes in Dextran - 40
density gradients. (A/A), normal erythrocytes? (S/S), sickle erythro¬
cytes. Top, middle cind bottom fractions are denoted.
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Figure 9, Scanning electron micrographs of fractions of normal and sickle
erythrocytes from Dextran density gradients. Top (T), middle (M),
bottom (B); normal (A/A), sickle (S/S). Magnification equals 4000X.
Photographs were made with a model OS 121 ETEC Omniscan Scanning
Electron Microscope.
 
Figure 10. Scanning electron micrographs of Dextran gradient bottom fractions of




EXAMINATION OF ERYTHROCYTE MEMBRANE PROTEIN COMPOSITION AFTER
SUBJECTING TO VARIOUS TYPES OF SDS-ELECTROPHORETIC AND STAINING
PROCEDURES
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) is a technique that is
widely used in research for fractionating membrane proteins. A previously reported
electrophoretic analysis has not revealed a difference between ISC and normal
cytoskeletal proteins (Lux et al., 1976). It is conceivable that the gel systems
employed may not have been of adequate resolving power to detect differences
between these two types of cytoskeletons. Recently, several refinements have been
made in SDS-poIyacryiamide gel electrophoresis and staining which permit greater
resolution of proteins. In the following analysis, the resolving power of several
procedures was analyzed. Total membrane proteins were subjected to electrophore¬
sis using the following systems. (1) A Tris-Acetate continuous buffer system and 4%
acrylamide disc gels (Fairbanks et al., 1971); (2) A Tris-Glycine Discontinuous Buffer
System and 10% acrylamide slab gels (Laemmli, 1970); (3) A Tris-Glycine Discontin¬
uous Buffer System and 5-15% acrylamide slcib gradient gels (Laemmli, 1970).
One of the criteria used to determine the system of choice was the ability to
separate band 4.1 (a cytoskeletal protein) into its individual components, bands 4.1a
and 4.1b. These two polypeptides co-migrate on less resolving systems because of
their close similarity in size. Band 4.1a has an estimated molecular weight of 80,000
daltons, whereas band 4.1b has an estimated molecular weight of 78,000 daltons.
Fig. 11 shows membrane proteins fractionated using the three different electro¬
phoretic systems described above. The Fairbanks system, the first system used
successfully to fractionate membrane proteins, yields good resolution of the major
membrane proteins however, bands 4.1a and 4.1b are not separated (Fig. 11, lane 1).
The Laemmli 10% acrylamide system seemed to improve resolution in the region
Figure 11. Examination of normal erythrocyte membrane protein composition
after various types of electrophoresis. Gels: 1) Fairbanks continuous
4% polyacrylamide disc gels; 2) Laemmli discontinuous 10% polyacryl¬
amide slab gel; 3) Laemmli gradient 5-15% polyacrylamide slab gel.
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between bands 4.1 and 5, but the high molecular weight proteins were not resolved
very well (Fig. 11, lane 2). The Laemmli 5-15% acrylamide gel system gave the best
resolution, resulting in the separation of 4.1a from 4.1b and at the same time
yielding relatively good resolution in the high molecular weight regions of the gel
(Fig. 11, lane 3). This latter system was subsequently routinely used to fractionate
cytoskeletal and membrane proteins.
In an attempt to detect minor membrane proteins, two newly developed
staining procedures were compared with the conventional staining procedure, which
employs Coomassie blue. One of the stains examined. Silver, has been rqjorted to
be 100 times more sensitive than Coomassie blue (Merril et al., 1982); while the
other stain, Gelcode was advertised (Upjohn Diagnostics) as having the potential to
stain proteins different colors. This latter property could conceivably permit
detection of differences between ISC and normal cytoskeletons.
Although some differences were observed. Silver stain and Gelcode did not
reveal many additional bands (Fig. 12). When gels were stained with Silver, in
contrast to Coomassie blue, diffuse staining was observed at the top of the gel and a
prominently stained band was observed between bands 3 and 4.1 (compare lane 2
with 1 and 4). These regions are unstained in gels stained with Coomsissie blue.
Since all of the bands detected with Coomassie blue are also detected with Silver
stain, the ctetection of additional staining regions increases our ability to detect
differences between sickle and normal membranes. The two regions stained with
Silver but not Coomassie blue are probably glycoproteins, since Silver stains
glycoproteins more readily than Coomassie blue (Merril et al., 1982). The band
between bands 3 and 4.1 seems to be in the position of Glycophorin A (PAS-1),
adding support to the hypothesis that the additional bands detected with Silver are
glycoproteins. Interestingly, band 3 does not stain very intensely when this stain is
used.
Figure 12. Examination of various protein staining procedures. Erythrocyte
membrane proteins electrophoresed on Laemmli gradient (5-15%) gels
stained with Gels; 1) Coomassie blue; 2) Silver; 3) Gelcode;
4) Coomassie blue. Asterisks indicate differences.
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Gels stained with Gelcode have a very interesting appearance but do not
photograph well (Fig. 12, lane 3). The major erythrocyte proteins, bands 1, 2 and 3
do not stain very well, although the other proteins detected by Coomassie blue are
stained (compare lanes 3 and 4). The band between bands 3 and 4.1 detected with
Silver, is also stained with Gelcode and several additional bands below band 7 are
seen in the Gelcode-stained gel but not the Coomassie blue stained gels. These
latter bands seem to be present in the Silver-stained gel although they are not
stained as intensely. All three stains were subsequently used to search for
alterations in the protein composition of ISC cytoskeletons.
COMPARATIVE ANALYSIS OF CYTOSKELETAL PROTEINS OF NORMAL (A/A).
IRREVERSIBLE AND NON-IRREVERSIBLE SICKLED CELLS, UTILIZING SDS-GEL
ELECTROPHORESIS
To detect possible differences in the protein composition of ISC and normal
erythrocyte cytoskeletons, cytoskeletal complexes were prepared from the top,
middle and bottom dextran gradient fractions of sickle and normal erythrocytes and
subjected to electrophoresis on SDS-polyacrylamide Laemmli gradient (5-15%) gels.
Gels were subsequently stained with Coomassie blue. Silver and Gelcode. Cytoskele¬
tons from cells in each of the different fractions were composed of the cytoskeletal
components; Spectrin, (bands 1 and 2), band 4.1 (a and b) and band 5 (actin). In
addition, other proteins were noted including the ankyrin family, band 7 and band
4.2. These latter proteins are frequently observed when cytoskeletons are prepared
from whole cells (Fig. 13). Each cytoskeletal fraction had the same protein
composition. Thus, no differences in either major or minor components were
observed after staining with Coomassie blue.
When another aliquot of this same sample was electrophoresed under identical
conditions and the gels stained with Silver (Fig. 14), no differences were detected
Figure 13. Comparison of cytoskeletal proteins from top, middle and bottom
fraction erythrocytes (normal and sickle) on Laemmli gradient (5-15%)
polyacrylamide slab gels, after staining with Coomassie blue. Lanes:
1) Whole membranes (A/A)j 2) Whole membranes (S/S); 3) Top frac¬
tions, normal cytoskeleton; 4) Middle fraction, normal cytoskeleton;
5) Bottom fraction, normal cytoskeleton; 6) Top fraction, sickle cyto¬







Figure 14. Comparison of cytoskeletal proteins from top, middle and bottom
fraction erythrocytes (normal and sickle) on Laemmli gradient poly¬
acrylamide slab gels, after staining with Silver. Electrophoresis was
carried out as described in Fig. 13.
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between the different fractions, though minor proteins were more visible in the 2.1
region. The bands detected in whole membranes with Silver but not Coomassie blue
do not appear to be associated with the cytoskeleton, again suggesting that they are
glycoproteins. Although band 7 seems to be absent in lanes 5-8, this is probably an
artifact of photography since it was detected in all lanes after Coomassie blue
staining (Fig. 13).
As in the above cases, when cytoskeletal proteins from the different fractions
were stained with Gelcode after electrophoresis, no differences were observed (Fig.
15), however of great interest, bands were observed which were not seen after
staining with either Coomassie blue or Silver. The lower part of the region between
4.2 and 5 contained several negatively stained bands and the region below band 7,
several positively stciined bands. These observations suggest that the cytoskeleton
may be more complex than presently imagined (Lux, 1979).
COMPARATIVE ANALYSIS OF CYTOSKELETAL PROTEINS OF NORMAL AND
IRREVERSIBLE SICKLED CELLS UTILIZING ISOELECTRIC FOCUSING AND TWO
DIMENSIONAL ELECTROPHORESIS
Isoelectric Focusing (lEF)
SDS-Polyacrylamide Gel Electrophoresis, the technique used in the preceeding
studies, fractionates proteins on the basis of size. Isoelectric focusing is another
analytical tool that is extremely useful for fractionating proteins species from
complex mixtures based on net charge.
The cytoskeletal preparations (sickle and normal) were focused over a pH
range of 2.9 (acidic end) to 7.1 at the (basic end) (Fig. 16-A). The pH gradient was
determined by a single contact electrode read with the standard pH meter.
Several modifications were made in the solubilizing buffer and electrophoresis
conditions during the course of this study (data not shown). The resolution
Figure 15. Comparison of cytoskeletal proteins from top, middle and bottom
fraction erythrocytes (normal and sickle) on Laemmli gradient poly¬
acrylamide slab gels, after staining with Gelcode. Electrophoresis was
carried out as described in Fig. 13.
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Figure 16. Isoelectric focusing of ISC and normal cytoskeletons and whole
membrane proteins. (A) pH gradient of blank gel following electro¬
phoresis. (B) lEF of cytoskeleton and membrane proteins: 1) Normal
cell membrane proteins; 2) ISC membrane proteins; 3) Normal cell











ultimately achieved was considered good (Fig, 16-B).
When ISC and normal cytoskeletal preparations were compared on lEF gels,
their protein profiles appeared identical (Fig. 16-B, lanes 4 and 5). Approximately
ten bands were visualized in each preparation. The major cytoskeletal polypeptides
i.e., bands 1, 2, 4.1 and 5 have been tentatively identified in the gel based on their
mobility when the gels were subjected to SDS gel electrophoresis, perpendicularly to
their long axis (two-dimensional electrophoresis).
The relatively simple protein profile of the cytoskeletal preparations versus
the more complex profile of the whole membrane preparations suggests that charge
modification, a frequently encountered problem associated with lEF, is not
occurring. It is of considerable interest, in view of the many similarities between
bands 1 and 2, that they seem to possess quite different isoelectric points (pis).
Two-Dimensional Electrophoresis (lEF/SDS PAGE)
This technique employs both Isoelectric Focusing (lEF) and SDS-Polyacryl-
amide gels (SDS-PAGE) to fractionate complex mixtures of proteins. The fact that
proteins are separated according to two parameters improves resolution when
compared to either one of the one-dimensional techniques.
Two-dimensional analysis of normal or ISC preparations revealed approxi¬
mately 40 different spots (Fig. 17), some of which were easily detected, while others
were somewhat obscure. Some of the spots have been identified, based on their
mobility in the second-dimension (SDS), e.g., actin is found in the lower plane of the
two-dimensional gel. The large number of spots seen in the two-dimensional
electrophoretogram is probably artifactual, since the cytoskeleton appears to
contain only five polypeptides when examined by SDS-gel electrophoresis (bands 1, 2,
4.1, 5 and 7), three of which (bands 1, 2 and 5) appear to be single polypeptides and
thus, should not be further fractionated by subjecting the sample to lEF.
Figure 17. Two-dimensional electrophoresis (lEF/SDS-PAGE) of cytoskeletal pro¬
teins (bottom fraction, normal and sickle). (A) Normal cytoskeletons;
(B) ISC cytoskeletons. Large arrows indicate the direction in which
the proteins moved. Small arrows denote the major cytoskeletal
proteins, i.e., bands 1, 2, 4.1a,b and 5.
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No significant differences between the ISC and normal cytoskeleton prepara¬
tion were observed.
COMPARATIVE ANALYSIS OF THE ORGANIZATION OF PROTEINS IN THE ISC
AND NORMAL CYTOSKELETON USING CROSSLINKING REAGENTS
It is probable that the proteins in ISC cytoskeietons are arranged differently
from those in normal biconcave erythrocyte cyto^eletons. To search for
organizational differences, a battery of crosslinking reagents was employed.
Crosslinking reagents are bifunctional molecules or catalysts which are able to
covalently link two closely associated proteins by serving as a bridge between or
catalyzing the covalent linkage of two similar chemical groups in the two proteins.
A number of these reagents are available commercially varying in reactive groups
and size. Fig. 18 shows the chemical structure of the crosslinking molecules
employed in this study. The asterisks point out the reactive groups for that
particular molecule.
E^reliminary experiments were conducted to determine the effective concen¬
tration and reactive conditions for each crosslinking reagent (data not shown). In
the studies reported here, ISC-rich and normal cytoskeietons were incubated with
one concentration of each crosslinking reagent and the crosslinked products
examined as a function of time.
O-phenanthroIine/Copper Sulfate
O-phenanthroline catalyzes the oxidation of sulfhydryl groups leading to the
formation of disulfide bonds between two such groups. Crosslinked complexes are
located at the top of the gel (depicted by arrows) and were observed even at 0 time
in both sickle and normal preparations (Fig. 19). There was a concommitant
reduction in bands 1, 2, 2.1, 4.1 and 7 as the time of incubation was increased,
indicating that these polypeptides were being crosslinked. Band 5 did not appear to
Figure 18. Chemical structures of the crosslinking reagents used in this study
(A) O-phenanthroline/Copper Sulfate (O-phe); (B) Glutaraldehyde
(Glute); (C) Dithiobis (succinimidyl propionate) (DTSP); (D) Dimethyl
3,3'dithiobispropionimidate-2HCl (DTBP); (E) Dimethyladipimidate
(DMA); and (F) Dimethylsuberimidate (DMS). Asterisks indicate the
reactive groups for each molecule. Arrows indicate bonds which can
be cleaved by reducing agents (e.g., Dithiothreitol (DTT) or 2-B-
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Figure 19. Crosslinking of cytoskeletons from (A) Normal and (B) ISC-rich cells
with 5mM O-phe/CuSO,^. Electrophoresis was carried out on 4%
Fairbeinks acrylamide gels, and the gels stained with Coomassie blue.
Gels; 1) Control membranes; 2) Control cytoskeletons; 3) Cytoskele¬
tons crosslinked for 0 min; 4) Cytoskeletons crosslinked for 10 min;
5) Cytoskeletons crosslinked for 20 min; 6) Cytoskeletons crosslinked
for 30 min. Arrows at the top of the photographs indicate crosslinked
products.
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be crosslinked in either preparation.
There seemed to be no difference between ISC and normal preparations in
either the kinetics of crosslinking or the crosslinked products which were formed.
Thus, this crosslinking reagent does not reveal a difference in the organization of
proteins in ISC and normal cytoskeletons.
Interestingly, hemoglobin was associated with the ISC-rich cytoskeleton and
appeared to be crosslinked as time increased.
Glutaraldehyde
Glutaraldehyde forms amide bridges between amino and carbonyl groups of
neighboring proteins. The crosslinked products were so large that they just entered
the gel (Fig. 20). Bands 1, 2, 2.1 and 4.1 appeared to be rapidly crosslinked, while
Band 7 seemed to be crosslinked relatively slowly. It is of interest that band 1
seemed to be crosslinked faster than 2, since 1 and 2 are intimately associated in the
cytoskeleton as dimers. As observed in the case of O-phenanthroline, band 5 was not
crosslinked to any significant extent.
Here again, no differences were detected between ISC and normal cytoskeletal
preparations, in either the kinetics of crosslinking or the crosslinked products
formed.
Dimethyl 3,3'- Dithiobispropionimidate (DTBP)
DTBP belongs to a class of crosslinking reagents called imidoesters. They
specifically react with proteins by amidination of primary amino groups.
Most of the crosslinked products produced with this reagent failed to enter the
gel, however a small fraction was contained within the gel (Fig. 21). Bands 1 and 2
showed a gradual reduction as time was increased but not as dramatically as when
exposed to other crosslinking reagents. Though 4.1 appeared in relatively low
concentration in the preparations (untreated cytoskeleton control), it is clear that
Figure 20. Crosslinking of cytoskeletons from (A) Normal and (B) ISC's with 5mM
Glutaraldehyde. Electrophoresis was carried out on 4% Fairbanks gels,
and the gels stained with Coomassie blue. Gels: 1) Control
membranes; 2) Control cytoskeletons; 3) Cytoskeletons crosslinked for
0 min; 4) Cytoskeletons crosslinked for 1 min; 5) Cytoskeletons
crosslinked for 2 min; 6) Cytoskeletons crosslinked for 3 min. Arrows






Figure 21. Crosslinking of cytoskeletons from (A) Normal and (B) ISC's with ImM
Dithiobis (succinimidyl propionate) (DTSP). Electrophoresis was
carried out on 4% Fairbanks gels, and the gels stained with Coomassie
blue. Gels: 1) Control membranes; 2) Control cytoskeletons; 3) Cyto¬
skeletons crosslinked for 0 min; 4) Cytoskeletons crosslinked for 1 min;
5) Cytoskeletons crosslinked for 2 min. Arrows at the top of the









there Wcis a rapid reduction or total disappearance of this band as a function of time
(Fig. 21, lane 6). Band 5 did not appear to be reduced, and therefore remained
uncrosslinked even under the most extreme crosslinking conditions.
No differences were observed between the ISC and normal cytoskeletal
preparations.
Dithiobis (Succinimidyl Propionate) (DTSP)
DTSP is a cleavable imidoester, which reacts similarly to DTBP. DTSP
crosslinked products constituted two to three bands in the upper quadrant of the gel
and also protein complexes which were too large to alter the gel (Fig. 22). All of
the cytoskeletal polypeptides appeared to be components of the crosslinked products
including band 5 as evidenced by the reduction in the intensity of bands.
There appeared to be a difference in the crosslinked products produced in the
sickle cind normal cytoskeletons. At 0 time, two crosslinked products seemed to be
common to both preparations, but there was a third unique band in the ISC
cytoskeleton. Other differences were noted after two min of reaction suggesting
that the crosslinking reaction was proceeding at a slower rate in the ISC
preparation; while these differences are interesting, it was not observed when two
other ISC cytoskeletal preparations were compared with normal after reacting with
DTSP. Thus, the significance of this observation is unclear.
Dimethyladipimidate (DMA)
DMA is an imidoester which like DTBP, reacts with primary amino groups,
forming amide linkages. The distance between reactive groups is approximately 8.6
o o
angstroms (A) whereas in DTBP it is approximately 11 A.
DMA was relatively ineffective in crosslinking cytoskeletal proteins (Fig. 23).
Although some polypeptides must have been crosslinked, based on the fact that
crosslinked products were present, a reduction in cytoskeletal polypeptides was not
Figure 22. Crosslinking of cytoskeletons from (A) Normal and (B) ISC's with
lOmg/ml Dimethyl 3,3'-dithiobispropionimidate - 2HC1 (DTBP). Elec¬
trophoresis was carried out on 4% Fairbanks gels, and the gels stained
with Coomassie blue. Gels; 1) Control membranes; 2) Control
cytoskeletons; 3) Cytoskeletons crosslinked for 0 min; 4) Cytoskeletons
crosslinked for 10 min; 5) Cytoskeletons crosslinked for 20 min;
6) Cytoskeletons crosslinked for 30 min. Arrows at the top of the







Figure 23. Crosslinking of cytoskeletons from (A) Normal and (B) ISC's with 60mM
Dimethyladipimidate (DMA). Electrophoresis was carried out in 4%
Fairbanks gels and the gels stained with Coomassie blue. Gels:
1) Control membranes; 2) Control cytoskeletons; 3) Cytoskeletons
crosslinked for 0 min; 4) Cytoskeletons crosslinked for 10 min;
5) Cytoskeletons crosslinked for 20 min; 6) Cytoskeletons crosslinked

















apparent. The crosslinked products in both ISC and normal cytoskeletal preparations
appeared to be the same.
Dimethylsuberimidate (DMS)
DMS, another imidoester, is very similar to DMA, but the reactive groups are
O
11 A apart. DMS was far more effective in crosslinking cytoskeletal preparations
than DMA (Fig. 24). Conceivably this is due to the fact that it is longer.
Bands 1, 2, and 4.1 were reduced with increasing time of crosslinking,
suggesting that they were the major components of the crosslinked complexes. In
contrast, the intensity of band 5 seemed to be relatively constant as a function of
time of crosslinking.
As with the other crosslinking reagents, no difference was observed between
ISC and normal cytoskeletons.
Figure 24. Crosslinking of cytoskeletons from (A) Normal and (B) ISC's with 80mM
Dimethylsuberimidate (DMS). Electrophoresis was carried out on 4%
Fairbanks gels, and the gels stained with Coomassie blue. Gels:
1) Control membranes; 2) Control cytoskeletons; 3) Cytoskeletons
crosslinked for 10 min; 5) Cytoskeletons crosslinked for 20 min;
6) Cytoskeletons crosslinked for 30 min. Arrows at the top of the





Studies by Lux et al. (1976) indicate that the defect(s) responsible for abnormal
cell shape of ISC’s resides within the cytoskeletal proteins. The primary goal of this
research was to define the defect(s) in the ISC cytoskeleton. The long range goal of
this project is to determine whether this defect is responsible for the abnormal cell
shape.
ISC's seem to play an important role in the expression of sickle cell anemia.
Infarction in the spleen (Sergeant, 1970) and conjunctiva (Sergeant et al., 1972), as
well as the degree of anemia (Sergeant et al., 1969), seem to be due to the presence
of ISC's. Although no good correlations have been established between the vaso-
occlusive ("pain") crisis and the presence of ISC's (Hebbel et al., 1979; Sergeant et
al., 1969; Steinberg et al., 1977) experimental results suggest that ISC's may initiate
this symptom of the disease (Klug et al., 1974).
In theory, there are two alterations of red cells that would restrict their
passage through capillaries: (1) reduced deformability and (2) increased adhesivity.
Several lines of evidence suggest that both of these alterations are characteristics
of ISC's. ISC's are less filterable than are normal cells (or non-ISC's) (Chien et al.,
1970) and this appears to be due to cellular dehydration (Shohet, 1979) and also
increased rigidity of the membrane (LaCelle and Kirkpatrick, 1975). It has been
shown recently that ISC's adhere more avidly to endothelial cells in culture than do
non-ISC's and that non-ISC's bind more tightly than normal cells. This may be due to
an abnormal distribution of negatively charged residues on the surface of the cell
(Hebbel et al., 1979). Although these latter investigators did not observe a
correlation between microvascular occlusions and ISC's, they did note a correlation
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between adherence to endothelial cells and the frequency of vaso-occlusive crisis.
While these data suggest that non-ISC's may also initiate vaso-occlusions, it seems
reasonable that ISC's play a disproportionate role since ISC's are the most adhesive
S/S erythrocytes. Possibly the correlation between ISC's and microveiscular
occlusions is masked due to the fact that many variables affect this symptom of the
disease.
There is reason to believe that a single defect in the cytoskeleton may be
responsible for abnormal ISC shape, rigidity and increased adhesivity. Since it has
been established that the ability to undergo changes in cell shape, i.e., the ability to
be deformed, is due to the cytoskeleton (Lange et al., 1982), this implies that the
irreversible deformation of the cytoskeleton should lead to increased membrane
rigidity. The hypothesis that the shape defect is also a possible cause of increased
adhesivity is supported by the observation that the specific aggregation of spectrin
causes changes on the external surface of the cell, and specifically, the aggregation
of negatively charged sites (Nicholson et al., 1971).
In order to detect defects in ISC cytoskeletons, they have been directly
examined with the electron microscope and by SDS-gel electrophoresis using the
Fairbanks system. No differences in the fine structure or protein composition were
observed (Lux et al., 1976). When ISC's are incubated in the presence of radioactive
32
phosphorous ( P), the B-chain of spectrin is phosphorylated less readily than the
corresponding polypeptide in normal cells (Dzandu and Johnson, 1980), and it has
been shown that a spectrin-rich polymer is formed more readily in ISC's than normal
cells upon ATP depletion. Although this latter change was not detectable with
either the crosslinking agents glutaraldehyde or o-phenanthroline, both studies
involving whole cells suggest that spectrin has an abnormal arrangement in the ISC
cytoskeleton. However, as previously mentioned, it has not been established
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whether the spectrin abnormalities detected in ISC's are a cause of its abnormal
shape.
While the above alterations have been detected in ISC cytoskeletons, it is
possible that other alterations exist. In recent years, a number of improvements
have been made in techniques to characterize proteins by electrophoresis, so that we
are now capable of achieving greater resolution than when the studies of Lux et al.
(1976) were performed. For example, two-dimensional electrophoresis is capable of
separating proteins which differ by only a single charge (O’Farrell, 1975). Moreover,
since the studies of Palek and Liu (1979), a variety of new crosslinking agents have
been synthesized. Because of the resolving capacity of these new techniques and
since the major objective of this work was to detect differences in ISC cytoskeleton
proteins, the methods used in this study were thought to be the most suitable ones.
Generally, the ISC cytoskeleton has been re-examined using a battery of
approaches which, when taken together, represents the most precise approach used
thus far to detect alterations in ISC cytoskeletons. Through use of Dextran-
gradients, a purer fraction of ISC's was obtained than previously isolated for studies
of cytoskeletal proteins. Analyses of these proteins on SDS-Laemmli-gradient gels
are shown in this study to be more resolving than electrophoretic systems previously
used. The use of several stains, which have only recently been used to detect
proteins in gels, have permitted detection of minor proteins. The data obtained in
this study lead me to conclude that the cytoskeleton may be more complex than
previously thought (Lux, 1979). Isoelectric focusing and two-dimensional electro¬
phoresis have not been used previously to analyze ISC cytoskeletal proteins. It was
thought, among the techniques selected for use in this investigation, that two-
dimensional electrophoresis had the greatest potential for revealing an alteration in
ISC cytoskeletal proteins.
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It is a reasonable assumption that the arrangement of proteins in ISC's is
altered, based on the fact that the ISC cytoskeleton has a different shape.
Crosslinking reagents are the best probes of supramolecular structure and have been
widely used to study the quaternary structure of proteins (Davies and Stark, 1970).
A variety of these reagents differing in mechanism of action and distance between
reactive groups were employed in order to maximize the possibility of detecting
differences in protein organization.
Although a variety of modern techniques were used to detect a difference in
ISC cytoskeletons, I have been unable to detect a difference in either the
composition or organization of proteins. There are several reasons why a defect
may not have been detected. First, it is possible that the actual concentration of
defective cytoskeletons in the bottom fraction was much less than indicated by the
ISC count (71%). If this was the case, the defect in the cytoskeleton may have been
masked by normal proteins. A second possible explanation is that the electropho¬
retic and crosslinking techniques were not sufficiently resolving to detect a
difference.
Lux et al. (1976) have shown that only 56% of the cells which maintain the
sickled shape after oxygenation, and are thus defined as ISC's, yield sickled-shaped
membranes. He has suggested that those cells yielding normally-shaped membranes
are actually incompletely oxygenated non-ISC's. If the percentage of oxygenated
sickled cells in the bottom fraction studied here yielding normally-shaped ghosts was
comparable to that in the experiments of Lux et al., then the percentage of
defective cytoskeletons may be as low as 35% rather than 71% suggested by the ISC
count.
There were several problems oicountered in performing the electrophoretic
and crosslinking experiments which may have limited their resolving power. The
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large number of prominent spots seen in two-dimensional gels on which cytoskeieton
preparations were electrophoresed is possibly artifactual because the conventional
view is that there are a limited number of polypeptides in the cytoskeieton (Lux,
1979). The observation that multiple spots appear on several horizontal planes in the
two-dimensional gels is evidence for charge modification (O'Farrell, 1975), and the
fact that a number of polypeptides differing in molecular weight appear focused the
same pi near the cathode end of the gel is evidence for aggregation of proteins
(O'Farrell, 1975). The fact that crosslinked intermediates were not observed,
coupled with the inability to resolve the various crosslinked complexes near the
origin of the gel, reduced the effectiveness of this technique.
In these studies, no alteration was detected in the ISC cytoskeieton, however,
several observations add to our understeinding of the erythrocyte cytoskeieton. The
five to six minor Gelcode-positive polypeptides of lower molecular weight than band
7, and the approximately six negatively-stained polypeptides in the 4.5 region
detected here, have not previously been reported. These findings suggest that the
cytoskeieton contains, in addition to five well-known polypeptides constituents, 1, 2,
4.1, 5 and 7, a number of minor polypeptide components.
It is also of considerable interest that band 5 is relatively resistant to being
crosslinked. Since a variety of crosslinking agents were used in this study, this
observation may indicate that band 5 (actin) has an unusual organization in the
cytoskeieton. Current models of the cytoskeieton indicate that bands 5 and 4.1 join
spectrin molecules in the network. Since both spectrin and band 4.1 are crosslinked
in the experiments reported here, it is puzzling that band 5 is not. Perhaps it is
arranged in the cytoskeieton in such a way that it is unaccessible to the crosslinking
reagents.
There are several technical improvements that could be made in order to
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increase the possibility of detecting an alteration in the ISC cytoskeleton.
Cytoskeletons have been viewed with the electron microscope (Lux et al., 1976; Yu
et al., 1973), and this technique was essential in order to determine whether ISC
cytoskeletons in my experiments were sickled-shaped. Several unsuccessful efforts
were made in the course of this work to view cytoskeletons with the electron
microscope; however, a recent work suggests that this is relatively easily done by
extracting cells with Triton after attaching them to poly lysine - coated grids (Sheetz
and Sawyer, 1978).
Assuming that some ISC's will yield normally-shaped cytoskeletons, it would be
useful to develop a method of fractionating cytoskeletons with sickled-shapes. The
transmission electron micrographs of Lux et al. (1976) suggest that the proteins in
the sickled-shaped ISC cytoskeleton are more dense than in normally-shaped
cytoskeletons. Thus, it may be possible to separate the two types of cytoskeletons
by density gradient centrifugation.
The two-dimensional electrophoretic analyses carried out here were not as
resolving as theoretically possible because of the apparent artifactual charge
modification and aggregation of proteins. There are several precautions that might
be utilized in future studies to minimize artifact (O'Farrell, 1975).
There are several improvements that can be made in the crosslinking analytic
procedure. In order for the very high molecular weight complexes to penetrate into
the gel so that they may be analyzed, the gel pore size can be increased by using a
lower concentration of acrylamide. In the studies described in this thesis, 4%
acrylamide gels were used. Peacock and Dingman (1968) has described a procedure
for making high porosity gels, using 1% acrylamide fortified with agarose.
The fact that intermediate crosslinked products were apparently not detected
in the gel further limited my ability to detect differences between ISC and normal
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cytoskeletal proteins. Further examination of various crosslinking lead to definition
of crosslinking conditions which yield intermediate crosslinked complexes.
Finally, a new method for analyzing cytoskeletal proteins which seems capable
of extremely high resolution, has recently been developed by Marchesi's group
(1983). The method involves fractionating proteolytic fragments of purfied proteins
by twonJimensional electrophoresis followed by isolation, subsequent proteolysis, and
finger printing (Ingram, 1956) of each molecular fragment obtained after the first
two-dimensional electrophoresis. This technique has been used to analyze the
spectrin molecule and, as cin indication of its high resolving power, spectrin from
normal erythrocytes from blacks has been shown to differ in one peptide from
spectrin obtained from normal erythrocytes from whites. Analysis of each
cytoskeleton protein in the ISC with this method may be the most resolving approach
to detect an ISC defect.
The most fundamental difference between the ISC and normal cytoskeleton
thus far reported is a reduction in the phosphorylation of band 2 in the ISC (Dzandu
and Johnson, 1980). Since band 2 is phosphorylated at four to five sites near its
carboxyl terminus in normal spectrin (Marchesi, 1983), it would be of interest to
determine which sites in ISC spectrin do not carry phosphate groups. Subsequent
studies could aim at establishing the mechanism by which the reduction in
phosphorylation occurs, and whether there is a causal relationship between this
defect and the abnormal cell shape.
The recent work of Hebbel et al. (1979) suggests that increased adhesivity of
ISC’s may be more important in causing vaso-occlusions than the reduced
deformability. If this is true, it may be profitable to attempt to better characterize
the molecular nature of the membrane surface defect. Of course, the next step
would be to establish the mechanism responsible for the molecular alteration in the
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surface. Since it has been shown that spectrin is connected to all external proteins
and carbohydrates via transmembrane proteins (Nicholson et al., 1971), it would be
of great interest to determine whether a defect in the cytoskeleton that is




Several conclusions were reached based on the data obtained in this study;
1. No difference can be detected between the protein composition of ISC
and normal erythrocyte cytoskeletons when analyzed on 5-15% gradient gels
utilizing the Laemmli buffer system, after staining with Coomassie blue, Silver, or
Gelcode.
2. No difference can be detected between the protein composition of ISC
and normal cytoskeletons when cinalyzed by Isoelectric Focusing and stained
conventionally.
3. No difference was detected in the protein composition of ISC and normal
erythrocyte cytoskeletons when analyzed by two-dimensional electrophoresis;
however, since artifactual spots were observed, it is not certain that this technique
may not yet reveal a difference between the two types of cytoskeletons.
4. No difference was detected in the protein organization of ISC and normal
erythrocyte cytoskeletons when analyzed with a battery of crosslinking reagents.
Although it is clear that a defect is present in the ISC cytoskeleton, it could
not be detected using the above techniques. However, in the course of this study,
several observations were made whidi may lead to new models of the cytoskeleton.
Several minor proteins were detected with Silver and Gelcode which had not been
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